Literature DB >> 24102345

The hypocretins/orexins: integrators of multiple physiological functions.

Jingcheng Li1, Zhian Hu, Luis de Lecea.   

Abstract

The hypocretins (Hcrts), also known as orexins, are two peptides derived from a single precursor produced in the posterior lateral hypothalamus. Over the past decade, the orexin system has been associated with numerous physiological functions, including sleep/arousal, energy homeostasis, endocrine, visceral functions and pathological states, such as narcolepsy and drug abuse. Here, we review the discovery of Hcrt/orexins and their receptors and propose a hypothesis as to how the orexin system orchestrates these multifaceted physiological functions.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  addiction; anxiety; arousal; hypothalamus; narcolepsy; neuropeptide; sleep; stress

Mesh:

Substances:

Year:  2014        PMID: 24102345      PMCID: PMC3904255          DOI: 10.1111/bph.12415

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  306 in total

1.  Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.

Authors:  R A España; B A Baldo; A E Kelley; C W Berridge
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Hypocretin/orexin suppresses corticotroph responsiveness in vitro.

Authors:  W K Samson; M M Taylor
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

3.  Central orexin-A augments sympathoadrenal outflow in conscious rabbits.

Authors:  K Matsumura; T Tsuchihashi; I Abe
Journal:  Hypertension       Date:  2001-06       Impact factor: 10.190

4.  Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.

Authors:  S Nishino; N Fujiki; B Ripley; E Sakurai; M Kato; T Watanabe; E Mignot; K Yanai
Journal:  Neurosci Lett       Date:  2001-11-09       Impact factor: 3.046

5.  Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.

Authors:  Y Yoshida; N Fujiki; T Nakajima; B Ripley; H Matsumura; H Yoneda; E Mignot; S Nishino
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

6.  Differential expression of orexin receptors 1 and 2 in the rat brain.

Authors:  J N Marcus; C J Aschkenasi; C E Lee; R M Chemelli; C B Saper; M Yanagisawa; J K Elmquist
Journal:  J Comp Neurol       Date:  2001-06-18       Impact factor: 3.215

7.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

8.  Orexin (hypocretin) neurons contain dynorphin.

Authors:  T C Chou; C E Lee; J Lu; J K Elmquist; J Hara; J T Willie; C T Beuckmann; R M Chemelli; T Sakurai; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

9.  Arousal effect of orexin A depends on activation of the histaminergic system.

Authors:  Z L Huang; W M Qu; W D Li; T Mochizuki; N Eguchi; T Watanabe; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

10.  Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.

Authors:  M A Dalal; A Schuld; M Haack; M Uhr; P Geisler; I Eisensehr; S Noachtar; T Pollmächer
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

View more
  74 in total

1.  Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor.

Authors:  David A Perrey; Nadezhda A German; Ann M Decker; David Thorn; Jun-Xu Li; Brian P Gilmour; Brian F Thomas; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

2.  What optogenetic stimulation is telling us (and failing to tell us) about fast neurotransmitters and neuromodulators in brain circuits for wake-sleep regulation.

Authors:  Elda Arrigoni; Clifford B Saper
Journal:  Curr Opin Neurobiol       Date:  2014-07-26       Impact factor: 6.627

3.  Early life social stress induced changes in depression and anxiety associated neural pathways which are correlated with impaired maternal care.

Authors:  Christopher A Murgatroyd; Catherine J Peña; Giovanni Podda; Eric J Nestler; Benjamin C Nephew
Journal:  Neuropeptides       Date:  2015-05-28       Impact factor: 3.286

4.  Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.

Authors:  Vijayakumar Mavanji; Claudio E Perez-Leighton; Catherine M Kotz; Charles J Billington; Sairam Parthasarathy; Christopher M Sinton; Jennifer A Teske
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

Review 5.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

6.  Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Brain Res       Date:  2016-10-19       Impact factor: 3.252

7.  Sleep-Dependent Structural Synaptic Plasticity of Inhibitory Synapses in the Dendrites of Hypocretin/Orexin Neurons.

Authors:  Idan Elbaz; David Zada; Adi Tovin; Tslil Braun; Tali Lerer-Goldshtein; Gordon Wang; Philippe Mourrain; Lior Appelbaum
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

8.  Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.

Authors:  Jie Yin; Kerim Babaoglu; Chad A Brautigam; Lindsay Clark; Zhenhua Shao; Thomas H Scheuermann; Charles M Harrell; Anthony L Gotter; Anthony J Roecker; Christopher J Winrow; John J Renger; Paul J Coleman; Daniel M Rosenbaum
Journal:  Nat Struct Mol Biol       Date:  2016-03-07       Impact factor: 15.369

Review 9.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

Review 10.  Deconstructing arousal into wakeful, autonomic and affective varieties.

Authors:  Ajay B Satpute; Philip A Kragel; Lisa Feldman Barrett; Tor D Wager; Marta Bianciardi
Journal:  Neurosci Lett       Date:  2018-01-31       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.